No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
665 |
4. Check minimum number of eventsNone |
665 |
5. Include endpointsNone |
665 |
6. Filter based on genotype QC (FinnGen only) |
665 |
Control definitions (FinnGen only)
- Control exclude
- G6_HYDROCEPH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified hydrocephalus
based on the number of shared cases.
Similar with more cases:
- Hydrocephalus
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6159 | 3013 | 3080 |
| Only index persons | 4640 | 2370 | 2270 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.09 | 0.09 |
| Only index persons | 0.09 | 0.09 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 56.12 | 58.51 | 53.59 |
| Only index persons | 54.55 | 57.40 | 51.57 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 665 | 366 | 299 |
| Unadjusted period prevalence (%) | 0.13 | 0.12 | 0.13 |
| Median age at first event (years) | 60.24 | 58.65 | 62.20 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 611
- Matched controls
- 6108
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
323.0
503
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
323.0
302
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
291.8
256
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
180.4
164
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
179.2
163
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
164.2
150
*
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
134.5
124
*
AAF00
NOMESCO Finland
Ventriculostomy
285.6
117.3
116
5
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
110.9
103
*
AA1AD
NOMESCO Finland
CT of head and brain
7.3
106.3
341
900
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
96.5
90
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
81.1
76
*
AA1AA
NOMESCO Finland
Head X-ray examination
74.1
79.0
89
14
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
14.4
73.1
129
111
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
61.5
58
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
649.3
60.8
59
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.2
52.8
140
243
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
56.6
44.4
52
10
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.3
44.4
128
245
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.2
43.8
129
253
R51.80
ICD-10 Finland
Headache
4.6
41.2
165
456
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
40.0
38
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
30.4
39.7
53
19
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
401.3
38.5
38
*
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
13.1
30.3
54
45
N03AX14
ATC
levetiracetam; systemic
9.7
29.9
62
70
34793
ICD-8 Finland
Other disease of brain, Hydrocephalus acquisitus NUD
+∞
28.3
27
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
28.0
94
210
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
43.5
27.0
33
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
26.5
156
575
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.5
26.5
83
171
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
+∞
26.2
25
*
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
+∞
26.2
25
*
N03AG01
ATC
valproic acid; systemic, rectal
5.2
24.9
81
174
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.7
24.4
64
105
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
9.9
23.2
47
51
2132
FHL
Ventricular operators sunt
+∞
22.0
21
*
G04BD07
ATC
tolterodine; oral
5.1
21.7
71
153
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.4
21.4
42
43
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
21.1
137
533
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
21.0
20
*
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
+∞
19.9
19
*
G93.0
ICD-10 Finland
Cerebral cysts
76.1
19.8
22
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.5
19.2
51
85
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
6.0
18.1
51
92
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
20.8
17.9
26
13
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
17.9
198
1034
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
+∞
17.8
17
*
Q03.9
ICD-10 Finland
Congenital hydrocephalus, unspecified
+∞
17.8
17
*
TAB00
NOMESCO Finland
Lumbar puncture
5.1
17.8
57
120
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
17.8
138
596
XA800
NOMESCO Finland
Neuropsychological investigation
5.2
17.2
54
111
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
16.5
17.2
27
17
L28
ICPC
Limited function/disability (L)
2.7
17.1
136
592
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
18.0
17.1
26
15
G93.2
ICD-10 Finland
Benign intracranial hypertension
+∞
16.7
16
*
2133
FHL
Suntin revisio
+∞
16.7
16
*
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
174.5
16.6
17
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
11.6
16.4
30
27
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
16.0
219
1250
R42
ICD-10 Finland
Dizziness and giddiness
2.3
15.9
177
918
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
+∞
15.7
15
*
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
87.4
15.6
17
*
F03
ICD-10 Finland
Unspecified dementia
4.2
15.3
59
151
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
8.8
15.2
32
38
R53
ICD-10 Finland
Malaise and fatigue
2.4
15.1
156
776
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
10.4
15.1
29
29
N05AH04
ATC
quetiapine; oral
2.7
14.9
115
487
A28
ICPC
Limited function/disability NOS
2.4
14.7
139
662
H47.1
ICD-10 Finland
Papilloedema, unspecified
27.9
14.3
19
7
N29
ICPC
Neurological sympt/complt other
7.5
14.2
33
46
G04BD08
ATC
solifenacin; oral
3.5
14.2
68
210
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
10.4
14.1
27
27
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
14.1
135
645
N18
ICPC
Paralysis/weakness
7.0
13.9
34
51
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.0
13.8
57
155
N05AX08
ATC
risperidone; systemic
3.3
13.7
71
233
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
76.9
13.6
15
*
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
76.9
13.6
15
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
11.3
13.6
25
23
G91
ICD-10 Finland
Hydrocephalus
+∞
13.6
13
*
Q03.0
ICD-10 Finland
Malformations of aqueduct of Sylvius
+∞
13.6
13
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
8.0
13.5
30
39
U04
ICPC
Incontinence urine
4.3
13.5
50
123
N30.0
ICD-10 Finland
Acute cystitis
2.5
13.3
112
500
T90.5
ICD-10 Finland
Sequelae of intracranial injury
15.5
13.2
21
14
A06AD11
ATC
lactulose; oral
2.4
12.9
117
541
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
20.6
12.5
18
9
N06AB04
ATC
citalopram; systemic
2.2
12.5
144
750
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
12.4
82
315
G04BD12
ATC
mirabegron; oral
2.8
12.2
81
313
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
12.0
59
186
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
47.6
11.9
14
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
9.2
11.8
24
27
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
9.2
11.8
24
27
N05BA01
ATC
diazepam; systemic, rectal
2.4
11.7
103
469
N05BA09
ATC
clobazam; oral
12.9
11.7
20
16
2130
FHL
Ventricular atrial shunt
+∞
11.5
11
*
N03AB02
ATC
phenytoin; systemic
8.1
11.5
25
32
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
35.7
11.3
14
*
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
35.7
11.3
14
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
11.2
64
225
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
6.0
11.2
30
52
SPAT1216
SPAT
Assessment of functional ability
2.2
11.1
123
627
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
12.2
10.9
19
16
N03AF02
ATC
oxcarbazepine; oral
4.2
10.8
41
104
183
Kela drug reimbursment
Lamotrigin and topiramate
10.3
10.6
20
20
S06.0
ICD-10 Finland
Concussion
2.6
10.6
80
336
N05AH03
ATC
olanzapine; systemic
3.6
10.5
48
143
N28
ICPC
Limited function/disability (N)
6.6
10.4
26
41
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.7
10.4
71
279
P20
ICPC
Memory disturbance
2.3
10.2
102
490
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
10.2
136
746
SPAT1229
SPAT
Assessment of need for aid
2.7
10.2
71
284
SPAT1301
SPAT
No procedures
1.8
10.1
208
1339
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
10.0
66
254
N03AF01
ATC
carbamazepine; oral, rectal
3.5
10.0
46
138
G04BD04
ATC
oxybutynin; oral, transdermal
3.2
10.0
52
172
R11
ICD-10 Finland
Nausea and vomiting
2.7
10.0
69
274
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
9.9
73
301
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.7
9.9
33
74
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
26.5
9.8
13
5
GBB00
NOMESCO Finland
Tracheostomy
10.9
9.8
18
17
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.0
9.8
26
45
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.7
9.7
16
12
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
9.7
72
299
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.9
9.7
39
105
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
9.7
109
555
SPAT1262
SPAT
Handing over of treatment supplies
2.1
9.6
119
634
G41.9
ICD-10 Finland
Status epilepticus, unspecified
17.9
9.4
14
8
N06AX11
ATC
mirtazapine; oral
1.8
9.4
189
1203
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
12.6
9.4
16
13
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
+∞
9.4
9
*
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
+∞
9.4
9
*
AAF10
NOMESCO Finland
Lumboperitoneal shunt
+∞
9.4
9
*
7423A
ICD-9 Finland
Other congenital anomalies of nervous system, Congenital hydrocephalus
+∞
9.4
9
*
74200
ICD-8 Finland
Congenital hydrocephalus, Communicans
+∞
9.4
9
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
9.4
115
605
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
9.3
40
922
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.3
9.3
87
407
N03AX18
ATC
lacosamide; systemic
11.7
9.1
16
14
N03AX09
ATC
lamotrigine; oral
3.8
9.1
38
106
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.3
9.1
45
144
H47.2
ICD-10 Finland
Optic atrophy
15.9
9.1
14
9
H53.4
ICD-10 Finland
Visual field defects
5.2
9.0
27
54
G81.1
ICD-10 Finland
Spastic hemiplegia
37.3
9.0
11
*
R50.9
ICD-10 Finland
Fever, unspecified
2.2
9.0
99
501
ZXC86
NOMESCO Finland
Use of endoscopic device
18.9
9.0
13
7
R41.0
ICD-10 Finland
Disorientation, unspecified
4.1
8.9
33
83
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
8.8
8.8
18
21
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
10.9
8.8
16
15
N06DA02
ATC
donepezil; oral
2.9
8.8
52
188
R32
ICD-10 Finland
Unspecified urinary incontinence
4.5
8.7
30
70
T85.7
ICD-10 Finland
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
50.7
8.7
10
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.7
8.6
61
245
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.6
8.6
64
265
WX402
NOMESCO Finland
General anaesthesia
2.1
8.5
96
489
K90
ICPC
Stroke/cerebrovascular accident
3.9
8.4
33
88
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
+∞
8.3
8
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.3
164
1031
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.2
8.3
19
27
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
8.2
91
461
N02BE01
ATC
paracetamol; systemic, rectal
1.8
8.1
502
4371
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
33.8
8.1
10
*
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
10.2
8.1
15
15
N99
ICPC
Neurological disease other
6.7
7.9
19
29
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
7.9
79
382
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.9
180
1179
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
7.8
106
583
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.2
7.8
23
46
N02AA05
ATC
oxycodone; systemic
2.0
7.6
101
549
TJD20
NOMESCO Finland
Change of gastrostomy tube
18.6
7.6
11
6
WX730
NOMESCO Finland
Conventional respirator
6.3
7.6
19
31
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
6.3
7.6
19
31
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
25.4
7.6
10
*
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
25.4
7.6
10
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
9.0
7.6
15
17
G40.10
ICD-10 Finland
Simple partial seizures
10.2
7.6
14
14
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
81.0
7.4
8
*
ABE50
NOMESCO Finland
Occipitocervical decompression
81.0
7.4
8
*
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
9.5
7.3
14
15
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.5
7.3
14
15
AAF45
NOMESCO Finland
Fenestration of intracranial cyst
+∞
7.3
7
*
AAW99
NOMESCO Finland
Other intracranial operation
+∞
7.3
7
*
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
+∞
7.3
7
*
G44.2
ICD-10 Finland
Tension-type headache
2.1
7.3
79
396
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
7.3
59
256
XKC03
NOMESCO Finland
Water cystometry
4.0
7.2
27
70
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
20.3
7.1
10
5
M03BX01
ATC
baclofen; systemic
6.1
7.1
18
30
G81.9
ICD-10 Finland
Hemiplegia, unspecified
7.1
7.0
16
23
R33
ICD-10 Finland
Retention of urine
2.5
7.0
55
236
N05CF01
ATC
zopiclone; oral
1.7
6.9
192
1324
PA2AD
NOMESCO Finland
CT angiography of brain
14.0
6.9
11
8
N05AB03
ATC
perphenazine; systemic, rectal
3.6
6.9
29
83
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.4
6.9
14
17
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.8
6.8
16
24
WX704
NOMESCO Finland
Intubation
2.6
6.8
50
205
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.6
6.8
48
196
A41.9
ICD-10 Finland
Sepsis, unspecified
3.2
6.7
34
112
N06AB10
ATC
escitalopram; oral
1.9
6.7
110
647
WYA20
NOMESCO Finland
Home visit
5.3
6.7
19
37
XCK00
NOMESCO Finland
Perimetry
2.6
6.7
49
201
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.9
6.6
14
18
J01EA01
ATC
trimethoprim; systemic
1.7
6.6
155
1018
H53.2
ICD-10 Finland
Diplopia
3.5
6.6
29
86
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.6
6.5
21
47
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.3
6.5
16
26
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.5
6.5
49
207
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.0
6.4
24
62
AAK80
NOMESCO Finland
Partial excision of skull cap
70.6
6.4
7
*
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
70.6
6.4
7
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.0
6.3
34
118
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
18.2
6.3
9
5
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
18.2
6.3
9
5
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
18.2
6.3
9
5
SPAT1053
SPAT
Memory test
1.8
6.3
106
626
N06AX16
ATC
venlafaxine; oral
2.0
6.3
76
400
R29.2
ICD-10 Finland
Abnormal reflex
+∞
6.3
6
*
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
+∞
6.3
6
*
2139
FHL
Other measure in this category
+∞
6.3
6
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
27.0
6.2
8
*
N30.9
ICD-10 Finland
Cystitis, unspecified
2.7
6.1
39
148
G03.9
ICD-10 Finland
Meningitis, unspecified
12.7
6.1
10
8
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
12.7
6.1
10
8
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
3.2
6.1
30
98
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.6
6.1
25
71
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
152
41
47.76
252.54
3.2
1.2
—
—
—
0
0
186
106
23.97
238.42
3.1
1.3
26.6
7.8
e6/l
1.41
158
76
186
106
23.97
238.42
3.2
1.3
1349.1
1249.6
e6/l
0.03
164
79
76
28
30.52
113.25
2.8
1.2
2.1
1.9
mmol/l
0.96
70
28
67
19
39.10
107.90
2.9
1.2
—
—
—
0
0
47
31
16.24
54.17
1.1
1.0
241.8
287.3
ng/l
0.46
18
21
47
31
16.24
54.17
1.1
1.0
613.6
618.9
ng/l
0.02
19
22
47
31
16.24
54.17
1.1
1.0
29.0
39.1
ng/l
0.60
17
20
51
64
8.55
38.44
5.3
5.9
10.5
10.9
mg/l
0.24
46
58
25
22
11.77
24.14
1.7
1.1
—
—
—
0
0
56
147
4.07
19.34
3.1
1.4
—
—
—
0
0
431
3133
2.07
17.35
8.7
5.0
6.7
6.7
mmol/l
0.02
420
2941
263
1611
2.05
17.04
2.8
2.1
147.7
300.1
u/l
1.72
250
1517
127
615
2.32
14.74
10.7
8.0
1.8
1.4
mmol/l
0.92
104
483
304
2051
1.89
14.15
4.3
3.8
74.0
56.5
ng/l
0.17
222
1464
373
2726
1.84
13.10
9.3
6.8
1.2
1.2
mmol/l
1.06
302
2303
224
1404
1.90
12.81
6.6
4.1
0.0
0.0
estimate
0.50
75
475
345
2506
1.78
11.95
9.8
6.2
1.2
1.2
mmol/l
4.08
321
2269
35
96
3.79
11.37
1.8
1.5
—
—
—
0
0
22
44
5.14
10.58
1.1
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
30
6.14
10.44
1.2
1.2
—
—
—
0
0
144
829
1.94
10.36
4.0
3.5
0.8
0.8
mmol/l
0.73
131
770
154
918
1.88
9.94
2.2
1.9
—
—
—
0
0
19
36
5.40
9.68
1.7
1.9
—
—
—
0
0
271
1948
1.66
8.93
4.2
3.4
—
—
—
0
0
99
525
2.04
8.93
5.0
3.7
—
—
—
0
0
116
652
1.94
8.87
2.2
1.8
—
—
—
0
0
116
654
1.94
8.79
2.3
1.9
—
—
—
0
0
16
29
5.63
8.53
1.2
1.0
1.4
1.1
u/l
—
9
19
114
648
1.92
8.41
8.4
7.2
—
—
—
0
0
68
332
2.17
7.59
2.1
1.4
—
—
—
0
0
52
227
2.40
7.54
2.9
1.9
0.6
2.6
ug/l
0.91
46
197
15
29
5.27
7.48
1.1
1.1
—
—
—
0
0
118
704
1.82
7.44
6.2
5.7
1.0
1.1
mmol/l
2.39
109
647
269
1999
1.58
7.37
6.7
4.0
—
—
—
0
0
11
7
15.94
7.25
1.5
1.0
—
—
—
0
0
161
1068
1.67
6.95
2.0
1.8
1369.9
1177.3
nmol/l
2.26
136
788
175
1192
1.64
6.80
6.5
4.1
1.0
1.0
kg/l
0.04
22
170
81
440
1.96
6.79
5.8
3.8
1.2
1.2
mmol/l
0.45
73
385
46
203
2.36
6.53
10.4
3.9
1.5
1.4
mmol/l
0.13
46
197
13
25
5.28
6.51
3.1
2.1
66.8
45.0
umol/l
1.40
13
17
421
3516
1.54
6.48
7.3
4.7
5305.0
2856.2
e6/l
—
8
64
17
42
4.13
6.39
1.4
1.2
0.7
1.1
promille
0.62
11
32
168
1159
1.60
6.12
3.6
2.7
7.1
5.6
e6/l
0.62
155
1017
167
1158
1.59
5.94
1.7
1.7
479.7
438.1
pmol/l
0.75
136
951
322
2573
1.49
5.91
6.1
3.8
0.0
0.0
estimate
0.00
75
486
30
115
2.68
5.72
3.7
2.5
17.3
16.1
%
0.93
16
56
62
327
1.99
5.66
11.0
8.9
95.1
94.3
%
0.69
62
322
18
55
3.34
5.06
1.2
1.1
—
—
—
0
0
460
5113
0.67
4.98
4.7
5.0
2.7
2.7
mmol/l
0.10
414
4670
298
2407
1.43
4.86
5.5
4.1
—
—
—
0
0
53
282
1.96
4.75
3.6
2.9
0.2
0.2
e6/l
0.15
53
274
217
1667
1.45
4.59
2.6
2.4
50.9
55.6
u/l
1.70
200
1552
317
2612
1.41
4.51
6.3
3.9
0.0
0.0
estimate
0.00
73
468
313
2582
1.40
4.39
8.1
5.3
0.0
0.0
estimate
0.00
76
479
12
31
3.92
4.27
14.3
15.4
1399.8
1469.9
nmol/l
0.10
12
31
449
4966
0.70
4.14
4.2
4.4
1.4
1.5
mmol/l
2.94
404
4538
280
2306
1.37
3.80
6.4
4.6
34.4
35.5
g/l
2.48
255
2132
455
5000
0.72
3.79
4.3
4.4
4.6
4.6
mmol/l
0.45
409
4600
11
30
3.71
3.65
9.7
11.3
686.6
812.3
nmol/l
0.36
11
30
15
381
0.38
3.64
1.5
1.7
—
—
—
0
0
329
2795
1.35
3.60
5.8
5.9
9.7
12.1
umol/l
4.35
307
2642
20
80
2.55
3.57
2.1
1.5
—
—
—
0
0
29
140
2.12
3.42
1.9
1.7
—
—
—
0
0
9
18
5.05
3.38
1.1
1.1
1927.0
1488.5
miu/ml
—
9
18
10
27
3.74
3.36
1.0
1.1
—
—
—
0
0
63
396
1.65
3.31
2.5
2.7
57.4
63.8
ml/min/173m2
0.53
23
166
228
1850
1.35
3.30
3.1
3.2
2.4
2.4
mmol/l
0.11
199
1603
28
136
2.11
3.27
2.0
1.7
—
—
—
0
0
192
1526
1.36
3.15
4.0
3.3
0.4
0.4
e6/l
0.40
165
1157
81
549
1.54
3.12
5.9
4.4
2.3
1.8
mmol/l
0.61
63
431
61
387
1.63
3.10
2.5
1.6
—
—
—
0
0
6
8
7.56
3.06
1.0
1.4
—
—
—
0
0
161
1258
1.37
2.92
2.9
2.4
—
—
—
0
0
440
4798
0.75
2.89
3.9
4.0
1.4
1.3
mmol/l
2.48
396
4363
101
729
1.45
2.88
24.4
25.7
1.2
1.2
inr
0.02
13
96
71
477
1.55
2.85
2.1
2.5
6.2
6.9
ug/l
0.08
59
417
74
503
1.53
2.83
2.3
2.0
380.2
385.4
nmol/l
0.07
66
461
8
18
4.48
2.80
1.1
1.2
—
—
—
0
0
8
18
4.48
2.80
1.0
1.2
—
—
—
0
0
8
18
4.48
2.80
1.0
1.1
—
—
—
0
0
40
656
0.58
2.80
4.0
4.4
30.4
32.1
%
0.60
32
429
5
7
7.19
2.55
1.2
1.6
—
—
—
0
0
8
21
3.84
2.47
1.1
1.0
—
—
—
0
0
5
8
6.29
2.37
1.0
2.0
19.7
14.7
umol/l
—
5
8
31
177
1.79
2.34
1.5
1.2
—
—
—
0
0
15
65
2.34
2.33
2.3
1.5
—
—
—
0
0
105
1359
0.73
2.30
1.7
1.7
1.5
1.4
mmol/l
1.15
84
1141
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
13
4.65
2.27
2.3
3.2
101.7
123.0
%
—
6
13
35
210
1.70
2.24
12.0
4.5
8.8
8.6
kpa
0.28
35
189
441
4750
0.79
2.19
5.9
5.9
39.9
40.0
mmol/mol
0.05
402
4376
465
4977
0.78
2.19
4.4
4.6
6.0
6.0
mmol/l
0.04
415
4490
9
30
3.03
2.15
1.4
1.2
—
—
—
0
0
438
4714
0.79
2.11
23.7
15.9
39.2
39.5
%
0.22
248
3319
7
179
0.38
2.04
1.1
1.7
—
266.7
—
0
6
7
21
3.36
1.97
1.1
1.3
—
—
—
0
0
14
64
2.21
1.95
1.2
1.3
—
—
—
0
0
134
1083
1.30
1.90
4.1
4.0
1129.8
369.6
ng/l
0.54
99
864
9
34
2.67
1.87
2.9
2.6
—
—
—
0
0
66
889
0.71
1.85
2.3
2.9
0.8
0.8
ug/l
0.19
46
583
157
1301
1.27
1.83
1.6
1.5
20.5
20.9
nmol/l
0.08
141
1091
551
5240
1.30
1.79
24.7
14.6
23.7
24.3
mg/l
0.13
474
4130
127
1028
1.29
1.78
2.7
2.9
2.5
2.5
mmol/l
0.69
116
896
18
98
1.86
1.63
1.6
1.6
—
—
—
0
0
5
14
3.59
1.62
1.0
1.9
4.7
3.9
umol/l
—
5
14
429
3992
1.21
1.57
4.1
3.8
15.3
14.8
pmol/l
3.11
387
3586
562
5381
1.29
1.57
28.1
17.3
139.7
139.6
mmol/l
0.25
549
5229
563
5393
1.29
1.56
27.1
17.4
4.0
4.0
mmol/l
2.50
549
5234
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
21
123
1.73
1.52
1.3
1.4
—
—
—
0
0
6
21
2.87
1.51
1.7
3.0
29.7
27.6
umol/l
—
6
21
12
228
0.52
1.48
2.5
1.8
—
—
—
0
0
54
397
1.39
1.46
9.2
4.9
2.3
1.9
mmol/l
0.42
44
298
0
39
0.00
1.34
0.0
1.3
—
24.0
—
0
5
159
1368
1.21
1.31
2.6
2.2
3.3
3.1
mg/l
0.20
137
1160
6
24
2.51
1.30
2.5
2.0
132.8
73.2
ug/l
—
6
24
17
99
1.74
1.28
2.5
1.6
—
—
—
0
0
11
55
2.02
1.28
1.1
1.2
—
—
—
0
0
9
44
2.06
1.27
2.6
1.6
—
—
—
0
0
42
305
1.40
1.25
5.8
4.8
24.5
24.0
mmol/l
0.73
37
276
8
36
2.24
1.24
1.1
1.0
—
—
—
0
0
12
63
1.92
1.23
1.3
1.7
—
—
—
0
0
65
820
0.77
1.21
1.2
1.3
9.0
10.8
u/ml
0.15
30
293
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
165
1.54
1.19
3.0
3.0
0.4
0.4
u/ml
0.25
14
91
0
33
0.00
1.16
0.0
1.2
—
16.3
—
0
27
0
34
0.00
1.16
0.0
1.2
—
69.7
—
0
29
5
20
2.51
1.15
1.0
1.2
0.3
0.3
g/l
—
5
15
55
424
1.32
1.14
9.5
4.8
5.4
5.2
kpa
0.87
55
392
12
65
1.86
1.14
2.3
1.7
32.2
32.7
pg
0.15
12
65
533
5518
0.83
1.13
11.1
10.2
27.4
25.9
u/l
0.55
512
5308
7
137
0.51
1.10
1.4
1.4
—
—
—
0
0
429
4057
1.16
1.08
7.4
7.2
83.3
80.6
u/l
0.41
401
3784
44
333
1.34
1.05
1.2
1.2
133.1
162.6
iu/ml
0.22
22
128
10
178
0.56
1.04
2.1
1.7
—
—
—
0
0
57
449
1.29
1.03
2.2
2.9
67.0
66.2
g/l
0.29
51
404
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
19
122
1.57
1.03
2.2
2.1
4710.4
4668.3
u/l
—
5
39
239
2174
1.16
1.01
2.5
2.3
74.9
77.7
nmol/l
0.76
218
1924
184
1644
1.16
0.98
2.9
3.2
978.5
1506.5
ng/l
1.89
156
1405
7
36
1.95
0.97
1.7
1.2
—
—
—
0
0
134
1168
1.18
0.97
2.0
1.8
2.3
1.2
mg/l
0.76
105
912
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
14
85
1.66
0.95
1.7
1.6
—
—
—
0
0
32
429
0.73
0.94
1.8
1.9
—
—
—
0
0
6
27
2.23
0.93
2.5
1.6
—
—
—
0
0
6
28
2.15
0.91
2.5
1.6
—
—
—
0
0
238
2178
1.14
0.91
2.1
2.0
93.2
94.0
pmol/l
0.10
128
1088
43
336
1.30
0.85
1.8
1.7
—
—
—
0
0
13
80
1.64
0.85
1.8
1.7
—
—
—
0
0
11
65
1.70
0.82
1.2
1.1
—
—
—
0
0
24
172
1.41
0.82
1.9
2.2
513.4
522.1
ug/l
0.01
18
159
37
473
0.77
0.80
1.9
2.1
—
—
—
0
0
38
483
0.77
0.79
2.8
2.4
28.7
31.1
u/l
0.30
29
401
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
460
4773
0.88
0.77
18.1
13.7
81.8
78.8
ml/min/173m2
1.83
395
3912
20
141
1.43
0.75
1.3
1.5
—
—
—
0
0
18
125
1.45
0.73
1.4
1.4
—
—
—
0
0
18
125
1.45
0.73
1.4
1.4
—
—
—
0
0
140
1556
0.87
0.73
3.8
4.9
3.8
2.7
ug/l
0.39
118
1386
9
57
1.59
0.71
1.4
1.8
—
—
—
0
0
5
26
1.93
0.70
1.4
2.9
1728.0
772.3
u/ml
—
5
26
22
161
1.38
0.69
12.4
5.8
1.9
1.5
mg/l
1.13
22
147
5
27
1.86
0.68
1.6
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
38.8
19.6
u/l
—
5
19
5
27
1.86
0.68
1.0
1.1
130.6
74.0
u/l
—
5
19
36
285
1.28
0.68
2.8
3.0
4.5
4.6
pmol/l
0.01
31
247
58
487
1.21
0.66
2.0
2.4
0.2
0.2
g/l
0.47
52
457
60
707
0.83
0.66
1.3
1.4
—
—
—
0
0
111
1244
0.87
0.65
3.2
4.3
18.0
21.7
%
2.22
49
588
52
433
1.22
0.65
3.3
3.9
91.0
82.6
ng/l
0.26
44
387
75
865
0.85
0.65
1.2
1.3
34.3
37.3
iu/ml
0.08
30
271
118
1315
0.88
0.64
2.8
2.7
341.2
6794.8
umol/l
5.44
103
1122
24
182
1.33
0.62
2.9
2.9
—
—
—
0
0
9
138
0.65
0.61
1.4
1.2
—
—
—
0
0
569
5799
0.87
0.59
33.9
21.5
131.0
134.4
g/l
6.09
557
5697
8
52
1.54
0.59
1.8
1.5
—
—
—
0
0
6
35
1.72
0.58
2.5
1.5
—
—
—
0
0
21
274
0.76
0.57
1.4
1.2
—
—
—
0
0
11
73
1.52
0.56
1.8
1.7
—
—
—
0
0
17
124
1.38
0.56
1.6
1.4
—
—
—
0
0
13
90
1.45
0.55
3.2
2.9
6.1
4.4
e9/l
0.54
13
90
6
38
1.58
0.54
2.2
2.3
0.1
0.2
e9/l
—
6
29
9
61
1.48
0.54
3.3
1.4
9.4
29.3
u/l
—
9
51
6
39
1.54
0.53
2.2
2.3
549.2
548.1
e6/l
—
6
29
48
562
0.84
0.51
4.0
3.8
4.6
30.4
ug/l
1.15
41
472
13
179
0.72
0.50
1.4
1.2
—
—
—
0
0
13
178
0.72
0.49
1.4
1.2
—
—
—
0
0
7
47
1.49
0.47
1.3
1.2
—
—
—
0
0
54
469
1.16
0.46
3.1
3.1
169.4
204.5
ng/l
0.33
47
426
28
341
0.81
0.46
2.1
2.2
13.9
12.8
nmol/l
0.28
22
307
7
49
1.43
0.46
2.3
2.3
—
—
—
0
0
5
81
0.61
0.46
1.0
1.1
—
—
—
0
0
13
96
1.36
0.42
4.8
3.1
64.7
58.5
%
0.69
13
96
0
19
0.00
0.39
0.0
1.2
—
17.0
—
0
12
12
156
0.76
0.35
1.6
1.6
—
—
—
0
0
26
218
1.20
0.34
1.9
1.9
—
—
—
0
0
21
172
1.23
0.34
3.3
2.0
—
—
—
0
0
12
91
1.32
0.34
1.4
1.4
180.9
243.4
u/ml
—
7
42
11
143
0.77
0.32
1.3
1.2
—
—
—
0
0
401
3911
1.06
0.32
3.9
4.1
15.0
12.6
mm/h
1.91
364
3578
10
75
1.34
0.30
1.9
1.5
—
—
—
0
0
22
185
1.20
0.29
1.2
1.2
0.3
2.1
u/ml
—
5
14
169
1610
1.07
0.28
3.4
3.2
7.3
7.4
mmol/l
0.03
145
1335
60
547
1.11
0.28
1.6
1.7
1.5
1.5
%
0.42
53
488
426
4344
0.95
0.27
27.0
17.9
13.8
13.7
%
0.74
419
4257
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
5
72
0.69
0.26
1.2
1.3
—
—
—
0
0
35
312
1.13
0.24
1.3
1.4
—
31.5
—
0
13
5
38
1.32
0.23
1.4
3.7
—
—
—
0
0
16
135
1.19
0.21
1.4
1.4
—
—
—
0
0
23
201
1.15
0.21
2.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
23.0
—
0
11
0
11
0.00
0.21
0.0
1.0
—
1.7
—
0
6
0
11
0.00
0.21
0.0
1.0
—
32.3
—
0
6
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
99
937
1.07
0.21
3.4
3.0
1.5
1.0
e6/l
0.63
72
544
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.16
0.21
1.4
2.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
2.2
—
0
6
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
49
1.23
0.20
2.0
1.2
3650.7
150371.6
e6/l
—
6
34
175
1689
1.05
0.20
3.8
3.1
58.5
33.8
u/l
0.46
166
1610
6
50
1.20
0.19
1.2
1.1
1.7
1.6
nmol/l
—
6
44
12
143
0.84
0.18
1.1
1.1
—
14.0
—
0
15
19
166
1.15
0.18
1.5
1.6
0.0
0.0
iu/ml
—
6
31
10
121
0.82
0.18
1.4
1.2
—
—
—
0
0
5
70
0.71
0.16
1.2
1.3
—
—
—
0
0
9
82
1.10
0.15
1.1
1.2
—
—
—
0
0
93
891
1.05
0.14
3.8
3.1
3.1
2.1
e6/l
0.45
66
498
23
208
1.11
0.14
1.6
2.0
7.0
7.5
g/l
0.37
14
154
23
208
1.11
0.14
1.6
2.0
—
—
—
0
0
60
631
0.95
0.13
2.6
2.8
5.8
7.7
umol/l
0.78
45
557
87
836
1.05
0.12
3.0
2.4
11.4
12.7
umol/l
0.84
76
769
153
1567
0.97
0.11
4.1
4.0
14.3
8.7
mg/mmol
0.49
102
985
25
269
0.93
0.10
4.2
2.9
45.2
68.6
u/ml
0.52
25
257
480
4766
1.03
0.09
5.0
4.7
2.0
2.2
mu/l
0.39
437
4319
11
124
0.89
0.09
1.3
1.7
40.8
40.8
nmol/l
0.00
11
119
325
3287
0.98
0.09
3.3
3.1
54.1
47.9
u/l
0.56
301
3058
11
97
1.14
0.09
1.5
1.4
—
—
—
0
0
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
21
195
1.08
0.08
1.4
2.0
9.4
10.1
g/l
0.52
16
167
311
3143
0.98
0.08
3.0
2.9
—
—
—
0
0
14
127
1.10
0.08
1.3
1.3
97.6
244.7
miu/ml
—
5
61
12
133
0.90
0.07
2.1
2.6
118.5
92.7
ug/min
—
7
81
6
71
0.84
0.07
1.5
1.4
—
—
—
0
0
304
3071
0.98
0.07
12.1
8.7
4.4
4.2
e9/l
0.65
282
2682
11
122
0.90
0.07
3.7
3.1
0.7
0.9
nmol/l
0.76
11
94
9
102
0.88
0.06
2.0
3.2
33.8
2778.3
u/ml
—
9
97
117
1150
1.02
0.05
1.3
1.3
1.0
2.2
u/ml
1.17
41
273
22
208
1.06
0.05
1.6
2.0
3.6
3.8
g/l
0.26
13
149
28
268
1.05
0.04
1.0
1.0
—
—
—
0
0
14
130
1.08
0.04
1.1
1.1
—
—
—
0
0
17
160
1.06
0.04
2.9
1.7
—
—
—
0
0
78
767
1.02
0.03
3.0
2.4
2.3
2.3
g/l
0.30
70
708
20
191
1.05
0.03
1.7
2.0
3.1
3.2
g/l
0.22
14
151
220
2212
0.99
0.02
3.0
2.7
113.5
127.7
ug/l
0.49
189
2022
85
857
0.99
0.01
1.6
1.5
—
—
—
0
0
27
276
0.98
0.00
13.9
5.2
25.0
24.9
mmol/l
0.10
27
266
12
124
0.97
0.00
1.4
1.3
—
—
—
0
0
14
138
1.01
0.00
1.8
1.3
—
—
—
0
0
72
717
1.00
0.00
3.2
2.4
20.3
22.4
%
0.73
56
616
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
1.6
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
0.00
1.2
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
3.7
—
55.6
—
0
7
5
53
0.94
0.00
1.2
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
0.00
1.0
1.3
0.6
0.6
nmol/l
—
6
55
5
53
0.94
0.00
1.2
1.7
—
—
—
0
0
5
53
0.94
0.00
1.2
1.7
—
—
—
0
0
12
120
1.00
0.00
1.2
1.3
—
—
—
0
0
5
53
0.94
0.00
2.2
1.3
90.8
59.6
%
—
5
36
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
8
87
0.92
0.00
1.4
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
7
74
0.95
0.00
1.1
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HCOTHUNS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCOTHUNS | 3.018 [2.63, 3.46] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.569 |
During the follow-up period (1.1.1998 — 31.12.2019), 789 out of 2228 females with G6_HCOTHUNS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCOTHUNS | 3.131 [2.67, 3.68] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 826 out of 2254 males with G6_HCOTHUNS died.
Mortality risk
Mortality risk for people of age
years, who have G6_HCOTHUNS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.299% | 0.595% |
| 5 | 2.223% | 3.345% |
| 10 | 5.219% | 8.599% |
| 15 | 10.012% | 15.221% |
| 20 | 16.312% | 24.269% |
Relationships between endpoints
↥Index endpoint: G6_HCOTHUNS – Other and unspecified hydrocephalus
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data